• Immunic granted inducement stock options covering 196,350 common shares to seven new employees between Sept. 14 and Sept. 28, 2026.
• Awards were issued under the Immunic 2026 Inducement Equity Compensation Plan.
• Options vest 25% on the first anniversary of each employee’s hire date.
• Remaining options vest monthly in 36 equal installments, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609291605PR_NEWS_USPR_____NY59394) on September 29, 2026, and is solely responsible for the information contained therein.